© 2004 BMJ Publishing Group Ltd & Association of Clinical Pathologists
ORIGINAL ARTICLE
KIT expression in fetal, normal adult, and neoplastic renal tissues
1 Laboratory of Histology and Embryology, Medical School, Aristotle University of Thessaloniki, GR54006 Thessaloniki, Greece
2 Department of Pathology, General Clinic of Thessaloniki, GR54645 Thessaloniki, Greece
3 Department of Pathology, Hippokrateion General Hospital, GR54639 Thessaloniki, Greece
Correspondence to:
Correspondence to:
Dr D Miliaras
Laboratory of Histology and Embryology, Medical School, Aristotle University of Thessaloniki, GR54006 Thessaloniki, Greece; miliaras{at}auth.gr
Background: KIT is a transmembrane tyrosine kinase receptor, expressed in high amounts in various normal cells. In addition, c-kit mutation or activation is a major pathogenetic event in certain tumours (such as gastrointestinal stromal tumours). There are only limited data in the literature on the expression of KIT in normal and neoplastic renal tissues.
Aims: To investigate KIT expression in normal and neoplastic renal tissues.
Methods: KIT expression was evaluated by means of immunohistochemistry in paraffin wax embedded sections from 67 tissue samples.
Results: Eight of eight fetal kidneys, and 10 of 10 normal adult kidneys revealed cytoplasmic staining of renal tubules. The three cases of renal dysplasia studied expressed KIT in their normal and aberrant tubules. Two of 13 conventional renal cell carcinomas (RCCs), two of seven papillary type RCCs, four of seven chromophobe type RCCs, none of six nephroblastomas, seven of seven oncocytomas, two of two mesoblastic nephromas, and two of four angiomyolipomas were positive.
Conclusion: KIT is expressed in normal fetal and adult renal tubules, and in a subset of renal tumours. The expression of KIT in these renal tumours may prove to have diagnostic relevance and/or therapeutic implications.
Keywords: KIT; renal cell carcinoma; oncocytoma; angiomyolipoma; mesoblastic nephroma
Abbreviations: CMN, congenital mesoblastic nephroma; GIST, gastrointestinal stromal tumour; RCC, renal cell carcinoma; SCF, stem cell factor
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Bengatta, S., Arnould, C., Letavernier, E., Monge, M., de Preneuf, H. M., Werb, Z., Ronco, P., Lelongt, B.
(2009). MMP9 and SCF Protect from Apoptosis in Acute Kidney Injury. J. Am. Soc. Nephrol.
20: 787-797
[Abstract] [Full Text] -
Jones, C., Rodriguez-Pinilla, M., Lambros, M., Bax, D., Messahel, B., Vujanic, G. M, Reis-Filho, J. S, Pritchard-Jones, K.
(2007). c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumours. J. Clin. Pathol.
60: 1226-1231
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
